The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Palonosetron 250 micrograms Solution for injection

Fresenius Kabi Deutschland GmbHPA2059/014/001

Main Information

Trade NamePalonosetron 250 micrograms Solution for injection
Active SubstancesPalonosetron hydrochloride
Dosage FormSolution for injection
Licence HolderFresenius Kabi Deutschland GmbH
Licence NumberPA2059/014/001

Group Information

ATC CodeA04AA Serotonin (5HT3) antagonists
A04AA05 palonosetron


License statusAuthorised
Licence Issued28/10/2016
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back